Computerized Tomography as First Coronary Study?

According to this new document recently published in JACC, a computerized tomography (CT) coronary angiography should be the first study done to diagnose a stable coronary artery disease.

ffr tomografia

A multidisciplinary group of experts recommends using computerized tomography as first-line diagnosis in stable patients. According to these professionals, guidelines should be updated soon.

Given the accruing evidence favoring anatomical studies (such as the PROMISE, the SCOT-HEART, and, more recently, the ISCHEMIA), this expert committee believes that computerized tomography offers the greatest benefit for patient management.

Despite the evidence supporting the benefits and even the savings in patients without known coronary disease, reality indicates that, for every 60 gamma-camera studies (single photon emission computed tomography, SPECT) only one tomography is conducted.


Read also: Visual Assessment for Non-Culprit Lesion Revascularization.


his could be partially due to the vast number of centers with nuclear medicine and stress echocardiography, the traditional idea that function supersedes anatomy, and the administrative difficulties faced by health systems in the payment of tomographies.

Both United Kingdom and European guidelines have been updated with the use of CT in chronic coronary syndromes, but the old school approach is still going strong in the United States. There might also be a lack of trained staff who can interpret the images.

We might be reaching a time when computerized tomography scans will completely replace us, and we will only enter the cath lab for therapeutic procedures.

Original Title: Current evidence and recommendations for coronary CTA first in evaluation of stable coronary artery disease.

Reference: Poon M et al. J Am Coll Cardiol. 2020;76:1358-1362.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...